Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2003 2
2004 2
2006 2
2007 1
2008 1
2009 1
2010 1
2012 2
2013 2
2014 16
2015 13
2016 14
2017 18
2018 11
2019 8
2020 8
2021 12
2022 10
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP. Goldsmith KC, et al. Among authors: desai av. Nat Med. 2023 May;29(5):1092-1102. doi: 10.1038/s41591-023-02297-5. Epub 2023 Apr 3. Nat Med. 2023. PMID: 37012551 Free PMC article. Clinical Trial.
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L, Whipple NS, Sabnis AJ, Foster JH, Shusterman S, Yoon J, Weiss BD, Abdelbaki MS, Armstrong AE, Cash T, Pratilas CA, Corradini N, Marshall LV, Farid-Kapadia M, Chohan S, Devlin C, Meneses-Lorente G, Cardenas A, Hutchinson KE, Bergthold G, Caron H, Chow Maneval E, Gajjar A, Fox E. Desai AV, et al. Neuro Oncol. 2022 Oct 3;24(10):1776-1789. doi: 10.1093/neuonc/noac087. Neuro Oncol. 2022. PMID: 35395680 Free PMC article. Clinical Trial.
Peptide hydrogen-bonded organic frameworks.
Vijayakanth T, Dasgupta S, Ganatra P, Rencus-Lazar S, Desai AV, Nandi S, Jain R, Bera S, Nguyen AI, Gazit E, Misra R. Vijayakanth T, et al. Among authors: desai av. Chem Soc Rev. 2024 Mar 7. doi: 10.1039/d3cs00648d. Online ahead of print. Chem Soc Rev. 2024. PMID: 38450536 Review.
The Evolution of Risk Classification for Neuroblastoma.
Sokol E, Desai AV. Sokol E, et al. Among authors: desai av. Children (Basel). 2019 Feb 11;6(2):27. doi: 10.3390/children6020027. Children (Basel). 2019. PMID: 30754710 Free PMC article. Review.
Author's Response.
Desai AV, Epstein AS, Colbert LE, Saltz LB. Desai AV, et al. J Pain Symptom Manage. 2018 Jan;55(1):e2-e3. doi: 10.1016/j.jpainsymman.2017.11.003. Epub 2017 Nov 13. J Pain Symptom Manage. 2018. PMID: 29146195 Free article. No abstract available.
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
Lerman BJ, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, Somers K, Ranavaya A, Weiss BD, Choe M, Foster JH, Pinto N, Morgenstern DA, Rafael MS, Streby KA, Zeno RN, Mody R, Yazdani S, Desai AV, Macy ME, Shusterman S, Federico SM, Bagatell R. Lerman BJ, et al. Among authors: desai av. J Clin Oncol. 2023 Jan 20;41(3):508-516. doi: 10.1200/JCO.22.01273. Epub 2022 Oct 7. J Clin Oncol. 2023. PMID: 36206505
Reply to K. Beiske et al.
Sokol E, Desai AV, Applebaum MA, Valteau-Couanet D, Park JR, Pearson ADJ, Schleiermacher G, Irwin MS, Hogarty M, Naranjo A, Volchenboum S, Cohn SL, London WB. Sokol E, et al. Among authors: desai av. J Clin Oncol. 2020 Nov 1;38(31):3720-3721. doi: 10.1200/JCO.20.02147. Epub 2020 Sep 15. J Clin Oncol. 2020. PMID: 32931402 No abstract available.
Stimulus-responsive metal-organic frameworks.
Nagarkar SS, Desai AV, Ghosh SK. Nagarkar SS, et al. Among authors: desai av. Chem Asian J. 2014 Sep;9(9):2358-76. doi: 10.1002/asia.201402004. Epub 2014 May 20. Chem Asian J. 2014. PMID: 24844581
Surface-Functionalized Metal-Organic Frameworks for Binding Coronavirus Proteins.
Desai AV, Vornholt SM, Major LL, Ettlinger R, Jansen C, Rainer DN, de Rome R, So V, Wheatley PS, Edward AK, Elliott CG, Pramanik A, Karmakar A, Armstrong AR, Janiak C, Smith TK, Morris RE. Desai AV, et al. ACS Appl Mater Interfaces. 2023 Feb 14;15(7):9058-65. doi: 10.1021/acsami.2c21187. Online ahead of print. ACS Appl Mater Interfaces. 2023. PMID: 36786318 Free PMC article.
125 results